Zacks Initiates Coverage of CTHRQ With Underperform Recommendation

Zacks initiated coverage of Charles & Colvard with an 'Underperform' rating, warning that weakening demand, margin erosion, persistent losses and liquidity pressure materially weaken the company's outlook. The analyst highlighted deteriorating fundamentals and constrained liquidity that increase refinancing and operational risk, suggesting downside risk to the equity.

Analysis

Zacks initiated coverage of Charles & Colvard with an 'Underperform' rating, warning that weakening demand, margin erosion, persistent losses and liquidity pressure materially weaken the company's outlook. The analyst highlighted deteriorating fundamentals and constrained liquidity that increase refinancing and operational risk, suggesting downside risk to the equity.